| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Type 2 Issues Articles
You often hear studies described as randomized, double blind, and crossover. That's supposed to be a good thing, but what exactly does it mean?
First of all, in a randomized study, the subjects are assigned at random to the experimental group and to the control group. If the assignments weren't random, the experimenters might unconsciously assign, for example, agreeable people to the test group and disagreeable people to the control group. That would influence how each group responded in the study.
In an open trial, both the researchers and the subjects know the full details of the treatment. These trials are vulnerable to the placebo effect; that is, because the subjects believe that the stuff they're testing should work, it does work. Sometimes an open trial is necessary; for example, it's pretty hard to conceal the details from a subject when they're getting a surgical treatment.
In a single blind experiment, the subjects do not know whether they are the test subjects or belong to the control group, but the experimenters do know. A single blind design is used when the experimenters must know the full facts in order to carry out the experiment. Because the experimenters know what's going on and have expectations about possible results, there is a risk that the subjects might respond to experimenter's bias: that is, the experimenters might give subconscious hints that influence how the subjects react to the experiment.
In a double-blind experiment, neither the subjects nor the researchers know who belongs to the control group and who belongs to the experimental group until long after the data is gathered. This lessens the influence of the scientists' expectations and unintentional physical cues on the subjects, helping to eliminate the placebo effect and experimenter's bias.
In a crossover study, each patient is given the test medication for a time and then the placebo for a time, in random order. A crossover study minimizes the variability between patients because each patient crossing over in effect serves as his or her own control.
As you can see, a randomized, double blind, crossover study is the best bet for achieving results that are untainted by the preconceptions and biases of both experimenters and subjects. That's why it's known as the gold standard of experimental design.
Categories: Professional Issues, Type 1 Issues, Type 2 Issues
Dec 4, 2007 -
Email to a Friend
Send a link to this page to your friends and colleagues.